Constellation Brands (STZ)
$252.29
1.70 (0.67%)
STZ Stock Quote Delayed 30 Minutes
Don’t Get Trapped by All the Hype Surrounding Cronos Stock
The big rally from Cronos Group stock has stalled, but too many investors are certain it's just a breather before another leg higher.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.07M
Day's Range
$251.88 - $255.09
52-Week Range
$227.50 - $274.87
Dividend & Yield
$3.56 (1.41%)
STZ Stock Predictions, Articles, and Constellation Brands News
Ride Cronos Stock’s Meteoric Rise … Before You Can’t
CRON is a hyper-momentum stock and there's no perfect time to buy it. Valuation aside, cannabis investing is young and the potential is great.
Is Aurora Cannabis the Best Pot Stock to Buy?
ACB stock had a 50% rally over just a few days earlier this month. Is it just resting before the next charge higher?
Cannabis-Infused Drinks Are a Slow Burn for NBEV Stock
NBEV stock hasn't raced higher like pot stocks have following recent cannabis-based news, but New Age Beverages is still well-positioned.
1.1 Million Reasons Why You Should Buy Constellation Stock
Constellation Brands stocks has been decimated, but there is opportunity. Bet with the former STZ stock CEO's 1.1 million new shares.
Constellation Brands Earnings: STZ Stock Dives on Outlook
The most recent Constellation Brands earnings report was bad news for STZ stock due to a poor guidance for its fiscal 2019.
Should You Buy Constellation Brands Stock After Its Earnings Plunge?
Constellation Brands earnings are not helping the stock, with STZ stock down about 10% after reporting third-quarter results.
Undervalued Constellation Stock Can Score a Pivotal Win in Q3
After taking a steep drop at the tail end of 2018, fundamentally attractive STZ stock is ready to right the ship off its Q3 earnings report.
Reality Starts to Rain on Canopy Growth Stock
CGC stock was red-hot just a few months ago, but the hype machine can only prop Canopy Growth shares up for so long.
Why Canopy Growth Stock Should Be in Your Sights
Of the whole bunch, CGC stock is the one to buy. This is a long-term bet and Canopy Growth will shrug this Wall Street malaise soon enough.
Aphria Stock Investors Balk At the Fine Print of Green Growth’s Offer
Aphria stock may be up on the heels of Green Growth Brands' offer, but it's still a relatively disappointing deal for APHA stock investors.
This Is the Best Way to Approach Cronos Stock Today
CRON stock should be on your radar as a trade, not a buy-and-hope investment. Here's what investors need to know about Cronos.
Is Tilray Stock a Must-Buy Following New Partnership?
Tilray stock is still very expensive, even after its partnership with Novartis' Sandoz. However, TLRY is in a very tradable range.
Canopy Growth Stock And Its Sister Company Are Both Attractive
If you’re thinking about buying Canopy Growth stock, before you buy CGC stock, you could consider investment company Canopy Rivers.
Did Altria Pay Too Much for Cronos Stock?
Altria stock wafted lower after announcing its investment in Cronos stock, and CRON is giving up gains too. What is going on?
STZ Downgrade Opens the Door for Analysts to Criticize CGC Stock
CGC stock has mostly held its ground after the pot stock craze, but pros might finally have room to point out problems with Canopy Growth.
